- Home
- RNW vs GPCR Comparison
RNW vs GPCR Comparison
Compare RNW & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNW
- GPCR
- Stock Information
- Founded
- RNW 2011
- GPCR 2016
- Country
- RNW United Kingdom
- GPCR United States
- Employees
- RNW N/A
- GPCR N/A
- Industry
- RNW Electric Utilities: Central
- GPCR
- Sector
- RNW Utilities
- GPCR
- Exchange
- RNW Nasdaq
- GPCR Nasdaq
- Market Cap
- RNW 2.1B
- GPCR 1.8B
- IPO Year
- RNW N/A
- GPCR 2023
- Fundamental
- Price
- RNW $5.39
- GPCR $34.17
- Analyst Decision
- RNW Strong Buy
- GPCR Buy
- Analyst Count
- RNW 3
- GPCR 5
- Target Price
- RNW $8.67
- GPCR $86.80
- AVG Volume (30 Days)
- RNW 612.6K
- GPCR 677.5K
- Earning Date
- RNW 11-19-2024
- GPCR 11-13-2024
- Dividend Yield
- RNW N/A
- GPCR N/A
- EPS Growth
- RNW N/A
- GPCR N/A
- EPS
- RNW 0.02
- GPCR N/A
- Revenue
- RNW $984,887,199.00
- GPCR N/A
- Revenue This Year
- RNW N/A
- GPCR N/A
- Revenue Next Year
- RNW $28.03
- GPCR N/A
- P/E Ratio
- RNW $218.12
- GPCR N/A
- Revenue Growth
- RNW 6.21
- GPCR N/A
- 52 Week Low
- RNW $5.15
- GPCR $26.61
- 52 Week High
- RNW $7.79
- GPCR $66.38
- Technical
- Relative Strength Index (RSI)
- RNW 38.90
- GPCR 35.81
- Support Level
- RNW $5.15
- GPCR $33.85
- Resistance Level
- RNW $5.60
- GPCR $38.48
- Average True Range (ATR)
- RNW 0.20
- GPCR 2.62
- MACD
- RNW -0.02
- GPCR -0.36
- Stochastic Oscillator
- RNW 28.92
- GPCR 3.67
About RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.